伴有破骨细胞样巨细胞的胆管肉瘤样癌1例报告

杨波; 刘小方

doi:10.3969/j.issn.1001-5256.2020.04.039

伴有破骨细胞样巨细胞的胆管肉瘤样癌1例报告

DOI: 10.3969/j.issn.1001-5256.2020.04.039

杨波,
刘小方

青岛大学附属烟台毓璜顶医院肝胆胰外科

详细信息

中图分类号: R735.8
计量
- 文章访问数: 633
- HTML全文浏览量: 7
- PDF下载量: 168
- 被引次数: 0
出版历程
- 出版日期: 2020-04-20

Sarcomatoid cholangiocarcinoma with osteoclast-like giant cells: A case report

Department of Hepatobiliary-Pancreatic Surgery, The Affiliated Yantai Yuhuangding Hospital of Qingdao University

摘要

摘要:
<正>胆管癌是起源于胆管上皮细胞具有高度侵袭性的胆道恶性肿瘤,其发病率和死亡率在全球范围内呈上升趋势。目前具有特殊的组织学表现的胆管肿瘤并不多见,其中上皮细胞肿瘤的肉瘤样变化可见于肝脏、胆囊、胰腺和壶腹部[1]。肉瘤样胆管癌是由上皮细胞和间质细胞组成的罕见肿瘤,大多数肉瘤样胆管癌具有肉瘤组分,表现为梭形细胞或多形性细胞分化。而伴有破骨细胞样巨细胞的胆管肉瘤样癌是一种非常罕见的恶性肿瘤,国内外文献少有报道,现就笔者所在医院诊断的1例伴破骨细胞样巨细胞的胆管肉瘤样癌,结合文献对其临床特点、病理学特征、诊治和预后进行初步探讨。
- 胆管肿瘤 /
- 肉瘤样癌 /
- 病理状态,体征和症状 /
- 诊断
- bile duct neoplasms /
- sarcomatoid carcinoma /
- pathological conditions,signs and symptoms /
- diagnosis

HTML全文

参考文献(14)

[1] ZHANG S,JIA J,BI X,et al. Sarcomatoid carcinoma of the common bile duct:A case report[J]. Medicine(Baltimore),2017,96(3):e5751.

[2] GANESHAN D,MORON FE,SZKLARUK J. Extrahepatic biliary cancer:New staging classification[J]. World J Radiol,2012,4(8):345-352.

[3] ALBRECHT T,MEHRABI A,STROBEL O,et al. Spindle and giant cell type undifferentiated carcinoma of the distal bile duct:A case report[J]. Z Gastroenterol,2019,57(1):52-56.

[4] ROSAI J. Carcinoma of pancreas simulating giant cell tumor of bone. Electron-microscopic evidence of its acinar cell origin[J]. Cancer,1968,22(2):333-344.

[5] HARATAKE J,YAMADA H,HORIE A,et al. Giant cell tumorlike cholangiocarcinoma associated with systemic cholelithiasis[J]. Cancer,1992,69(10):2444-2448.

[6] LIAO X,HOULDSWORTH J,LUO J,et al. Polypoid undifferentiated carcinoma with osteoclast-like giant cells arising in the distal common bile duct:A rare case report[J]. Anticancer Res,2019,39(1):437-441.

[7] XU RF,SUN JP,ZHANG SR,et al. KRAS and PIK3CA but not BRAF genes are frequently mutated in Chinese cholangiocarcinoma patients[J]. Biomed Pharmacother,2011,65(1):22-26.

[8] GARG M. Epithelial-mesenchymal transition-activating transcription factors-multifunctional regulators in cancer[J]. World J Stem Cells,2013,5(4):188-195.

[9] SUNG CO,CHOI H,LEE KW,et al. Sarcomatoid carcinoma represents a complete phenotype with various pathways of epithelial mesenchymal transition[J]. J Clin Pathol,2013,66(7):601-606.

[10] KIM HJ,KIM JS,JOO MK,et al. Hepatolithiasis and intrahepatic cholangiocarcinoma:A review[J]. World J Gastroenterol,2015,21(48):13418-13431.

[11] XU J,LI JD. Diagnosis and treatment experience of intrahepatic hepatolithiasis associated with cholangiocarcinoma[J/CD]. Chin J Liver Dis:Electronic Edition,2018,7(2):115-118.(in Chinese)徐建，李敬东．肝内胆管结石合并胆管癌诊治经验[J/CD]．中华肝脏外科手术学电子杂志，2018,7(2):115-118.

[12] WATANABE M,CHIGUSA M,TAKAHASHI H,et al. High level of CA19-9,CA50,and CEA-producible human cholangiocarcinoma cell line changes in the secretion ratios in vitro or in vivo[J]. In Vitro Cell Dev Biol Anim,2000,36(2):104-109.

[13] LIU YB,WANG XA. Problems and strategy in surgical treatment of biliary tract tumors[J]. Chin J Dig Surg,2019,18(2):117-122.(in Chinese)刘颖斌，王许安．胆道恶性肿瘤外科治疗的问题和对策[J]．中华消化外科杂志，2019,18(2):117-122.

[14] NAKAJIMA T,TAJIMA Y,SUGANO I,et al. Intrahepatic cholangiocarcinoma with sarcomatous change. Clinicopathologic and immunohistochemical evaluation of seven cases[J]. Cancer,1993,72(6):1872-1877.

施引文献

资源附件(0)

访问统计